- CALM Phase 3 program consists of two pivotal trials (CALM-1 and CALM-2), with primary efficacy endpoint of 24-hour cough frequency measured at 12- and 24-weeks, respectively - - The Company has reached alignment with FDA on the primary efficacy endpoi
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES SASKATOON, Saskatchewan & LONDON--(BUSINESS WIRE)--Gensource Potash Corporation (“Gensource” or the “Company”) (TSXV: GSP, AIM: GSP) announced today that follow
Initial Results from Clinical Trial on Lung Lesion Detection Will be Presented at ECR 2022 WATERLOO, Ontario--(BUSINESS WIRE)--#ECR2020--KA Imaging, a company that develops innovative X-ray imaging solutions, announced the initial results from a study ex
The Board of Directors unanimously recommends that shareholders vote FOR the Arrangement Not for distribution to U.S. news wire services or for dissemination in the U.S. TORONTO--(BUSINESS WIRE)--LifeWorks Inc. (TSX: LWRK, “LifeWorks” or the “Comp
TORONTO--(BUSINESS WIRE)--The Ontario Bioscience Innovation Organization (OBIO®), a not-for-profit organization dedicated to advancing health technology innovation and commercialization, is excited to announce the expansion of Canada’s Early Adopter He
-- Expected to accelerate clinical development pathway of CYB004 for the potential treatment of anxiety disorders by nine months -- TORONTO--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“Cybin” or the “Company”), a biopharmaceutic
Led by Dr. Eugenio Bortone, one of the world’s preeminent food scientists and extrusion processing experts, and inventor of Frito-Lay’s Twisted Cheetos, Sapientia has created and filed multiple foundational patents within the multi-billion-dollar g
Former Amazon financial operations excellence leader and leading e-commerce platform strategist to assist Flora with financial discipline and reporting Garayev brings 25 years of financial leadership experience at Amazon, Boeing, BP and RPK Capital, a
DARTMOUTH, Nova Scotia & CAMBRIDGE, Mass.--(BUSINESS WIRE)--IMV Inc. (“IMV” or the “Company”) (NASDAQ: IMV; TSX: IMV), a clinical-stage company developing a portfolio of immune-educating therapies based on its novel DPX™ platform to treat solid
CHAPEL HILL, N.C. & TORONTO & LONDON & ZUG, Switzerland--(BUSINESS WIRE)--#Europe--AESARA is pleased to announce the new entrants to its two-year Doctor of Pharmacy fellowship program, Denise Garner, PharmD, Ashik Jayakumar, PharmD, Fadi Manuel, PharmD an
BAM's 2023 Most Promising Bioscience Student, Daniel Gussakovsky, and recent scholarship winner, shares about his research, why he's chosen it, and what he hopes to do in the future with it.
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.